154 related articles for article (PubMed ID: 37666976)
1. Development of a highly-efficient erythrocyte-drug covalent conjugation platform and its use in treating thrombotic disorders.
Huang Y; Nie X; Liu X; Liu Y; Yu H; Gao X
Cell Res; 2023 Nov; 33(11):887-890. PubMed ID: 37666976
[No Abstract] [Full Text] [Related]
2. Ginsenoside Rg3, a component of ginseng, induces pro-thrombotic activity of erythrocytes via hemolysis-associated phosphatidylserine exposure.
Bian Y; An GJ; Kim K; Ngo T; Shin S; Bae ON; Lim KM; Chung JH
Food Chem Toxicol; 2019 Sep; 131():110553. PubMed ID: 31163221
[TBL] [Abstract][Full Text] [Related]
3. [Role of erythrocytes in thromboembolism pathology].
Wautier JL
Ann Med Interne (Paris); 1986; 137(6):477-9. PubMed ID: 3813282
[TBL] [Abstract][Full Text] [Related]
4. Effect of Progesterone and Synthetic Progestins on Whole Blood Clot Formation and Erythrocyte Structure.
Swanepoel AC; Emmerson O; Pretorius E
Microsc Microanal; 2017 Jun; 23(3):607-617. PubMed ID: 28480839
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte oxidative stress and thrombosis.
Bettiol A; Galora S; Argento FR; Fini E; Emmi G; Mattioli I; Bagni G; Fiorillo C; Becatti M
Expert Rev Mol Med; 2022 Aug; 24():e31. PubMed ID: 36017709
[TBL] [Abstract][Full Text] [Related]
6. Low-level mercury can enhance procoagulant activity of erythrocytes: a new contributing factor for mercury-related thrombotic disease.
Lim KM; Kim S; Noh JY; Kim K; Jang WH; Bae ON; Chung SM; Chung JH
Environ Health Perspect; 2010 Jul; 118(7):928-35. PubMed ID: 20308036
[TBL] [Abstract][Full Text] [Related]
7. New advances in treating thrombotic diseases.
Schumacher WA; Wang X; Wong PC
Drug Discov Today; 2014 Sep; 19(9):1433-4. PubMed ID: 24959954
[No Abstract] [Full Text] [Related]
8. Flavonoids and Platelet-Derived Thrombotic Disorders.
Lopez JJ; El Haouari M; Jardin I; Alonso N; Regodon S; Diez-Bello R; Redondo PC; Rosado JA
Curr Med Chem; 2019; 26(39):7035-7047. PubMed ID: 29667548
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Quality Marker (Q-Marker) of Danhong Injection by the Zebrafish Thrombosis Model.
Qi Y; Zhao X; Liu H; Wang Y; Zhao C; Zhao T; Zhao B; Wang Y
Molecules; 2017 Aug; 22(9):. PubMed ID: 28858254
[TBL] [Abstract][Full Text] [Related]
10. Increased erythrocyte sedimentation rate following anti-thrombotic treatment with dextrans.
Ro JS; Kluge T
Scand J Thorac Cardiovasc Surg; 1971; 5(1):47-50. PubMed ID: 5115431
[No Abstract] [Full Text] [Related]
11. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis.
Jang IK; Gold HK; Ziskind AA; Fallon JT; Holt RE; Leinbach RC; May JW; Collen D
Circulation; 1989 Apr; 79(4):920-8. PubMed ID: 2494006
[TBL] [Abstract][Full Text] [Related]
12. Development of Orally Active Thrombin Inhibitors for the Treatment of Thrombotic Disorder Diseases.
He LW; Dai WC; Li NG
Molecules; 2015 Jun; 20(6):11046-62. PubMed ID: 26083038
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte migration and gap formation in rabbit blood clots in vitro.
Ueki T; Yazama F; Horiuchi T; Yamada M
Vet Res Commun; 2008 Apr; 32(4):315-23. PubMed ID: 18085421
[TBL] [Abstract][Full Text] [Related]
14. Novel engineering: Biomimicking erythrocyte as a revolutionary platform for drugs and vaccines delivery.
Izzati Mat Rani NN; Alzubaidi ZM; Azhari H; Mustapa F; Iqbal Mohd Amin MC
Eur J Pharmacol; 2021 Jun; 900():174009. PubMed ID: 33722591
[TBL] [Abstract][Full Text] [Related]
15. Stasis Promotes Erythrocyte Adhesion to von Willebrand Factor.
Smeets MWJ; Mourik MJ; Niessen HWM; Hordijk PL
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1618-1627. PubMed ID: 28775074
[TBL] [Abstract][Full Text] [Related]
16. [The role of the thrombocyte and erythrocyte components of hemostasis in the development of thrombohemorrhagic complications in patients with systemic lupus erythematosus].
Gritsiuk AI; Ivanova NV; Vas'kova NG; Kosiuk LN; Poltavets NI
Vrach Delo; 1990 Dec; (12):21-3. PubMed ID: 2089792
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria.
Van Bijnen ST; Van Heerde WL; Muus P
J Thromb Haemost; 2012 Jan; 10(1):1-10. PubMed ID: 22077430
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte aging as a mechanism of anemia and a biomarker of device thrombosis in continuous-flow left ventricular assist devices.
Taimeh Z; Koene RJ; Furne J; Singal A; Eckman PM; Levitt MD; Pritzker MR
J Heart Lung Transplant; 2017 Jun; 36(6):625-632. PubMed ID: 28396088
[TBL] [Abstract][Full Text] [Related]
19. Filterability and cerebro-vascular thrombosis. Study on the mechanism.
Lorient-Roudaut MF; Manuau JP; Bricaud H; Boisseau MR
Scand J Clin Lab Invest Suppl; 1981; 156():203-8. PubMed ID: 6948387
[TBL] [Abstract][Full Text] [Related]
20. [Rheologic modifications induced by heparin therapy. Capillary blood viscosity, erythrocyte deformability, aggregation index].
Achilli E; Cortinovis A; Ardemagni P; Crippa A
Minerva Cardioangiol; 1999 Apr; 47(4):95-119. PubMed ID: 10416313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
